Shares of Arena Pharmaceuticals, Inc. ARNA are down sharply this morning, after the FDA did not approve its weight loss drug, lorcaserin.
The link to the FDA's ruling can be found here.Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
